These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

419 related articles for article (PubMed ID: 19135050)

  • 41. Consecutive pharmacological activation of PKA and PKC mimics the potent cardioprotection of temperature preconditioning.
    Khaliulin I; Parker JE; Halestrap AP
    Cardiovasc Res; 2010 Nov; 88(2):324-33. PubMed ID: 20558443
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Interactions of GSK-3β with mitochondrial permeability transition pore modulators during preconditioning: age-associated differences.
    Zhu J; Rebecchi MJ; Glass PS; Brink PR; Liu L
    J Gerontol A Biol Sci Med Sci; 2013 Apr; 68(4):395-403. PubMed ID: 23070879
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Long-term oral resveratrol intake provides nutritional preconditioning against myocardial ischemia/reperfusion injury: involvement of VDAC1 downregulation.
    Liao Z; Liu D; Tang L; Yin D; Yin S; Lai S; Yao J; He M
    Mol Nutr Food Res; 2015 Mar; 59(3):454-64. PubMed ID: 25488258
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evidence that hydroxysafflor yellow A protects the heart against ischaemia-reperfusion injury by inhibiting mitochondrial permeability transition pore opening.
    Liu YN; Zhou ZM; Chen P
    Clin Exp Pharmacol Physiol; 2008 Feb; 35(2):211-6. PubMed ID: 17941891
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Intralipid protects the heart in late pregnancy against ischemia/reperfusion injury via Caveolin2/STAT3/GSK-3β pathway.
    Li J; Ruffenach G; Kararigas G; Cunningham CM; Motayagheni N; Barakai N; Umar S; Regitz-Zagrosek V; Eghbali M
    J Mol Cell Cardiol; 2017 Jan; 102():108-116. PubMed ID: 27847332
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Curcumin protects against regional myocardial ischemia/reperfusion injury through activation of RISK/GSK-3β and inhibition of p38 MAPK and JNK.
    Jeong CW; Yoo KY; Lee SH; Jeong HJ; Lee CS; Kim SJ
    J Cardiovasc Pharmacol Ther; 2012 Dec; 17(4):387-94. PubMed ID: 22396328
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Diabetes mellitus abrogates erythropoietin-induced cardioprotection against ischemic-reperfusion injury by alteration of the RISK/GSK-3β signaling.
    Ghaboura N; Tamareille S; Ducluzeau PH; Grimaud L; Loufrani L; Croué A; Tourmen Y; Henrion D; Furber A; Prunier F
    Basic Res Cardiol; 2011 Jan; 106(1):147-62. PubMed ID: 20981553
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Investigating and re-evaluating the role of glycogen synthase kinase 3 beta kinase as a molecular target for cardioprotection by using novel pharmacological inhibitors.
    Nikolaou PE; Boengler K; Efentakis P; Vouvogiannopoulou K; Zoga A; Gaboriaud-Kolar N; Myrianthopoulos V; Alexakos P; Kostomitsopoulos N; Rerras I; Tsantili-Kakoulidou A; Skaltsounis AL; Papapetropoulos A; Iliodromitis EK; Schulz R; Andreadou I
    Cardiovasc Res; 2019 Jun; 115(7):1228-1243. PubMed ID: 30843027
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Role of glycogen synthase kinase-3beta in cardioprotection.
    Juhaszova M; Zorov DB; Yaniv Y; Nuss HB; Wang S; Sollott SJ
    Circ Res; 2009 Jun; 104(11):1240-52. PubMed ID: 19498210
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Inhibition of phosphodiesterases leads to prevention of the mitochondrial permeability transition pore opening and reperfusion injury in cardiac H9c2 cells.
    Chanoit G; Zhou J; Lee S; McIntosh R; Shen X; Zvara DA; Xu Z
    Cardiovasc Drugs Ther; 2011 Aug; 25(4):299-306. PubMed ID: 21643720
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Astragaloside IV inhibits oxidative stress-induced mitochondrial permeability transition pore opening by inactivating GSK-3β via nitric oxide in H9c2 cardiac cells.
    He Y; Xi J; Zheng H; Zhang Y; Jin Y; Xu Z
    Oxid Med Cell Longev; 2012; 2012():935738. PubMed ID: 23050041
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Paraoxonase 2 protects against acute myocardial ischemia-reperfusion injury by modulating mitochondrial function and oxidative stress via the PI3K/Akt/GSK-3β RISK pathway.
    Sulaiman D; Li J; Devarajan A; Cunningham CM; Li M; Fishbein GA; Fogelman AM; Eghbali M; Reddy ST
    J Mol Cell Cardiol; 2019 Apr; 129():154-164. PubMed ID: 30802459
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Enhancing AMPK activation during ischemia protects the diabetic heart against reperfusion injury.
    Paiva MA; Rutter-Locher Z; Gonçalves LM; Providência LA; Davidson SM; Yellon DM; Mocanu MM
    Am J Physiol Heart Circ Physiol; 2011 Jun; 300(6):H2123-34. PubMed ID: 21421816
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Inhibition of GSK3beta by postconditioning is required to prevent opening of the mitochondrial permeability transition pore during reperfusion.
    Gomez L; Paillard M; Thibault H; Derumeaux G; Ovize M
    Circulation; 2008 May; 117(21):2761-8. PubMed ID: 18490522
    [TBL] [Abstract][Full Text] [Related]  

  • 55. GSK-3β at the crossroads in the signalling of heart preconditioning: implication of mTOR and Wnt pathways.
    Vigneron F; Dos Santos P; Lemoine S; Bonnet M; Tariosse L; Couffinhal T; Duplaà C; Jaspard-Vinassa B
    Cardiovasc Res; 2011 Apr; 90(1):49-56. PubMed ID: 21233250
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Helium-induced early preconditioning and postconditioning are abolished in obese Zucker rats in vivo.
    Huhn R; Heinen A; Weber NC; Kerindongo RP; Oei GT; Hollmann MW; Schlack W; Preckel B
    J Pharmacol Exp Ther; 2009 May; 329(2):600-7. PubMed ID: 19244549
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Activation of G protein-coupled oestrogen receptor 1 at the onset of reperfusion protects the myocardium against ischemia/reperfusion injury by reducing mitochondrial dysfunction and mitophagy.
    Feng Y; Madungwe NB; da Cruz Junho CV; Bopassa JC
    Br J Pharmacol; 2017 Dec; 174(23):4329-4344. PubMed ID: 28906548
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Post-ischaemic activation of kinases in the pre-conditioning-like cardioprotective effect of the platelet-activating factor.
    Penna C; Mognetti B; Tullio F; Gattullo D; Mancardi D; Moro F; Pagliaro P; Alloatti G
    Acta Physiol (Oxf); 2009 Nov; 197(3):175-85. PubMed ID: 19432589
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Melatonin protects against heart ischemia-reperfusion injury by inhibiting mitochondrial permeability transition pore opening.
    Petrosillo G; Colantuono G; Moro N; Ruggiero FM; Tiravanti E; Di Venosa N; Fiore T; Paradies G
    Am J Physiol Heart Circ Physiol; 2009 Oct; 297(4):H1487-93. PubMed ID: 19684190
    [TBL] [Abstract][Full Text] [Related]  

  • 60. GSK3beta inhibition and K(ATP) channel opening mediate acute opioid-induced cardioprotection at reperfusion.
    Gross ER; Hsu AK; Gross GJ
    Basic Res Cardiol; 2007 Jul; 102(4):341-9. PubMed ID: 17450314
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.